Brilinta Monotherapy Reduces Clinically Relevant Bleeding Risk Post-PCI in High-Risk Patients

Press/Media

Period	26 Sep 2019

Media coverage

Title	Brilinta Monotherapy Reduces Clinically Relevant Bleeding Risk Post-PCI in High-Risk Patients
Media name/outlet	Diagnostic & Invasive Cardiology
Country/Territory	United States
Date	26/09/19
URL	https://www.dicardiology.com/content/brilinta-monotherapy-reduces-clinically-relevant-bleeding-risk-post-pci-high-risk-patients
Persons	Roxana Mehran,